NCT02714231View on ClinicalTrials.gov

Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Family Planning
Interventions
DRUG

diclofenac sodium (cataflam)

The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure

DRUG

hyoscine butyl bromide (buscopan)

The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02714231 - Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion | Biotech Hunter | Biotech Hunter